Skip to main content
Go to the home page of the European Commission (opens in new window)
English English
CORDIS - EU research results
CORDIS

Enabling Surgical Pocket REgeneration

Project description

An invisibility cloak on medical implants

Our body perceives implanted medical devices as foreign objects and attempts to reject them, leading to significant complications. To overcome this issue, the EU-funded ESPREE project proposes to use Hylomate®, the world’s first solution that offers protection to all implantable medical devices from foreign body reaction. It interacts with the surrounding tissue of the surgical pocket to prevent infection, haematoma and fibrotic encapsulation. This increases the lifetime of the medical device and improves patient health. During the project, Hylomate® will be used in devices associated with the management of cardiac rhythm such as pacemakers, while future applications will include breast reconstruction and nerve repair.

Objective

All medical devices implanted into the human body are perceived as foreign objects resulting in an attempt by the body to reject them through a process called foreign body reaction. This can result in either the failure of the medical device and/or significant clinical complications.
Hylomorph has developed Hylomate®, the world’s first solution to protect all implantable medical devices in contact with soft tissues from foreign body reaction, acting as an “invisibility” cloak through complex interactions at the microscopic level with the surrounding tissue.
Hylomate® is a platform technology that addresses all causes of severe complications connected to the implantation of synthetic materials. It ensures an all-round protection of the surgical pocket, preventing infection, hematoma, foreign body reaction and fibrotic encapsulation. Hylomate® increases the lifespan of implants and minimizes exposure to life-threatening risks. This results in (1) improved quality-of-life for patients, (2) better quality-of-care for healthcare providers and (3) reduced health economics burdens.
The first application for Hylomate® will be in the field of cardiac rhythm management in combination with pacemakers, implantable cardioverter defibrillators, and cardiac resynchronization therapy devices. Other applications are currently under development in the field of breast reconstruction, aesthetics and nerve repair.

Fields of science (EuroSciVoc)

CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.

You need to log in or register to use this function

Keywords

Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)

Programme(s)

Multi-annual funding programmes that define the EU’s priorities for research and innovation.

Topic(s)

Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.

Funding Scheme

Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.

SME-2 - SME instrument phase 2

See all projects funded under this funding scheme

Call for proposal

Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.

(opens in new window) H2020-EIC-SMEInst-2018-2020

See all projects funded under this call

Coordinator

HYLOMORPH AG
Net EU contribution

Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.

€ 1 493 865,00
Address
TECHNOPARKSTRASSE 1
8005 Zurich
Switzerland

See on map

SME

The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.

Yes
Region
Schweiz/Suisse/Svizzera Zürich Zürich
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Total cost

The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.

€ 2 134 093,75
My booklet 0 0